Conformis (CFMS) Short Interest Ratio & Short Volume

Short interest is the volume of Conformis shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 83,600 shares of CFMS short. 1.12% of Conformis' shares are currently sold short. Learn More on Conformis' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.12% of Conformis' floating shares are currently sold short.

Conformis saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 83,600 shares, an increase of 0.8% from the previous total of 82,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Conformis currently has issued a total of 7,878,000 shares. Some of Conformis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Conformis currently has a public float of 7,440,000 shares.

1.12% of Conformis' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Conformis: vTv Therapeutics Inc. (1.55%), Veru Inc. (12.01%), Adverum Biotechnologies, Inc. (10.27%), Nutriband Inc. (3.57%), Milestone Pharmaceuticals Inc. (5.66%), Cyclacel Pharmaceuticals, Inc. (0.22%), Sensus Healthcare, Inc. (6.46%), BeyondSpring Inc. (6.28%), Exicure, Inc. (3.34%), 111, Inc. (0.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling CFMS is an investing strategy that aims to generate trading profit from Conformis as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Conformis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CFMS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CFMS, twice per month. The most recent reporting period available is August, 15 2023.